{"id":"NCT00443209","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Telcagepant (MK-0974) Long-Term Safety Study in Adult Participants With Acute Migraine (MK-0974-012)","officialTitle":"A Multicenter, Double-Blind, Active-Controlled, Parallel Group Study to Examine the Safety, Tolerability and Efficacy of Oral MK-0974 for the Long Term Treatment of Acute Migraine With or Without Aura","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-02-21","primaryCompletion":"2009-01-22","completion":"2009-01-22","firstPosted":"2007-03-05","resultsPosted":"2014-08-18","lastUpdate":"2018-10-17"},"enrollment":1068,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Migraine"],"interventions":[{"type":"DRUG","name":"Telcagepant 300 mg soft gel capsules","otherNames":[]},{"type":"DRUG","name":"Telcagepant 280 mg tablets","otherNames":[]},{"type":"DRUG","name":"Rizatriptan 10 mg tablets","otherNames":[]},{"type":"DRUG","name":"Placebo to telcagepant capsules","otherNames":[]},{"type":"DRUG","name":"Placebo to telcagepant tablets","otherNames":[]},{"type":"DRUG","name":"Placebo to rizatriptan tablets","otherNames":[]}],"arms":[{"label":"Telcagepant 280 mg/300 mg","type":"EXPERIMENTAL"},{"label":"Rizatriptan 10 mg","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to investigate the safety and tolerability of telcagepant (MK-0974) in the long-term treatment of acute migraine in adult participants. The primary hypothesis of this study is that telcagepant is well tolerated in the long-term treatment of acute migraine in adult participants.","primaryOutcome":{"measure":"Percentage of Participants With At Least One Triptan-Related Adverse Experience (AE)","timeFrame":"Within 14 days of any dose of study drug (Up to 18.5 months)","effectByArm":[{"arm":"Telcagepant 280 mg/300 mg","deltaMin":5,"sd":null},{"arm":"Rizatriptan 10 mg","deltaMin":11.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["21070230"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":641},"commonTop":["Somnolence","Dry mouth","Dizziness","Nausea","Fatigue"]}}